D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
InnoPharmax Inc.
InnoPharmax Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Fudan University
Curtin University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Janssen Research & Development, LLC
Shanghai Shengdi Pharmaceutical Co., Ltd
ImmunityBio, Inc.
Sun Yat-sen University
AbbVie
CSPC Megalith Biopharmaceutical Co.,Ltd.
University Hospital, Caen
Nurix Therapeutics, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Alliance for Clinical Trials in Oncology
Merck Sharp & Dohme LLC
Ruijin Hospital
NRG Oncology
Fudan University
AstraZeneca
Groupe Oncologie Radiotherapie Tete et Cou
Rovi Pharmaceuticals Laboratories
Fudan University
Shanghai Zhongshan Hospital
Boehringer Ingelheim
Karolinska Institutet
Institute of Hematology & Blood Diseases Hospital, China
BeOne Medicines
Regeneron Pharmaceuticals
Queensland Centre for Gynaecological Cancer
UNICANCER
Merck Sharp & Dohme LLC
Shenzhen TargetRx Co., Ltd.
Hunan Province Tumor Hospital
The First Affiliated Hospital of Soochow University
The Netherlands Cancer Institute
GlaxoSmithKline
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Franciscus Gasthuis & Vlietland (Hospital)
PETHEMA Foundation
Protara Therapeutics
University Health Network, Toronto
UCB Pharma
Charite University, Berlin, Germany
Regeneron Pharmaceuticals
Catharina Ziekenhuis Eindhoven
Pharmacosmos A/S